What is LBRX's proceeds from warrant exercises?

LBRX (LBRX) reported proceeds from warrant exercises of $29K in Q1 2026.

What does proceeds from warrant exercises mean?

Measures the cash inflows received by the company when holders of warrants exercise their rights to purchase common stock at a predetermined price. This serves as a source of non-dilutive or secondary capital and indicates investor confidence in the company's long-term valuation.

LBRX LBRX Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

Zevra Therapeutics, Inc.ZVRA

$9.17M—

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$888.98M+163%

Enterprise value$571.77M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's proceeds from warrant exercises?: LBRX (LBRX) reported proceeds from warrant exercises of $29K in Q1 2026.
What does proceeds from warrant exercises mean?: Measures the cash inflows received by the company when holders of warrants exercise their rights to purchase common stock at a predetermined price. This serves as a source of non-dilutive or secondary capital and indicates investor confidence in the company's long-term valuation.